<DOC>
	<DOCNO>NCT02499900</DOCNO>
	<brief_summary>The primary objective study compare patient medication satisfaction measure Medication Satisfaction Questionnaire ( MSQ ) score Copaxone 40 mg/mL three time week ( TIW ) group Copaxone 20 mg/mL daily ( QD ) group 6 month treatment .</brief_summary>
	<brief_title>Study Assess Medication Satisfaction Patients With Relapsing Remitting Multiple Sclerosis Treated With CopaxoneÂ®</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>1 . Men woman least 18 year age old . 2 . Patients must confirm documented RRMS diagnosis 3 . Patients must ambulatory Kurtzke EDSS score 0 5.5 screen visit . 4 . Patients must stable neurological condition , relapsefree free corticosteroid treatment 30 day prior randomization . 5 . Women childbearing potential must negative urine pregnancy test screen visit must practice acceptable method birth 6 . Patients must able sign date write informed consent prior enter study . 7 . Patients must willing able comply protocol requirement duration study . Exclusion Criteria 1 . Patient contraindication Copaxone therapy . 2 . Previous use Copaxone 40 mg/mL three time per week . 3 . Patients progressive form MS. 4 . Patients neuromyelitis optica . 5 . Use experimental investigational drug , and/or participation drug clinical study within 6 month prior screen . 6 . Patients treat ; immunosuppressive medication , immunoglobulin and/or monoclonal antibody , alemtuzumab , cladribine , cyclophosphamide mitoxantrone time 7 . Chronic ( 30 consecutive day ) systemic ( IV , PO IM ) corticosteroid treatment within 6 month prior screen visit . 8 . Pregnancy breastfeed . 9 . Clinically significant unstable medical surgical condition would preclude safe complete study participation 10 . Employees clinical study site individual involve conduct study , immediate family member individual criterion may apply , please contact investigator information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>